Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values

被引:76
作者
Bon, GG
Kenemans, P
Verstraeten, R
vanKamp, GJ
Hilgers, J
机构
[1] VRIJE UNIV AMSTERDAM,ACAD HOSP,DEPT OBSTET & GYNECOL,1081 HV AMSTERDAM,NETHERLANDS
[2] VRIJE UNIV AMSTERDAM,ACAD HOSP,DEPT CLIN CHEM,1081 HV AMSTERDAM,NETHERLANDS
关键词
ovarian cancer; breast cancer; CA; 125; 15.3; tumor markers; reference values;
D O I
10.1016/S0002-9378(96)70381-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to establish reference values for six monoclonal antibody-based serum immunoassays applied in patients with carcinoma of the female genital tract. STUDY DESIGN: Sera from 938 healthy women (median age 48.0 years, range 37 to 76 years) were assayed for levels of CA 125, CA 15.3 (two methods), CA M29, CA M26, and mucin-like cancer antigen (MCA). RESULTS: Reference values, defined as those including 95% of healthy controls, were in women with unknown menopausal status as follows. CA 125, 37 U/ml; CA 15.3 (Centocor), 33 U/ml; CA 15.3 (Boehringer Mannheim), 28 U/ml; CA M26, 83 U/ml; CA M29, 13 U/ml; and MCA, 19 U/ml. Postmenopausal values were significantly lower for CA 125 and CA M26 and significantly higher for CA M29 and CA 15.3 (both methods). MCA serum levels were age independent. CONCLUSION: Reference values found were not in accord with those generally applied in gynecologic oncology. In addition, serum levels were influenced significantly by menopausal status (except with MCA).
引用
收藏
页码:107 / 114
页数:8
相关论文
共 26 条
[1]   MCA, A MONOCLONAL-ANTIBODY-DEFINED BREAST-TUMOR-ASSOCIATED ANTIGEN AND ITS RELATION TO CA-15.3 [J].
BIEGLMAYER, C ;
SZEPESI, T ;
NEUNTEUFEL, W ;
NOWOTNY, C .
TUMOR BIOLOGY, 1989, 10 (05) :232-242
[2]  
BOMBARDIERI E, 1989, CANCER, V63, P490, DOI 10.1002/1097-0142(19890201)63:3<490::AID-CNCR2820630317>3.0.CO
[3]  
2-4
[4]  
BON GG, 1990, J NUCL MED ALLIED S, V34, P151
[5]  
BROWN J, 1989, IMMUNODIAGNOSIS CANC, P69
[6]   CIRCULATING CA 15-3 LEVELS IN THE POSTSURGICAL FOLLOW-UP OF BREAST-CANCER PATIENTS AND IN NON-MALIGNANT DISEASES [J].
COLOMER, R ;
RUIBAL, A ;
GENOLLA, J ;
RUBIO, D ;
DELCAMPO, JM ;
BODI, R ;
SALVADOR, L .
BREAST CANCER RESEARCH AND TREATMENT, 1989, 13 (02) :123-133
[7]  
DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS
[8]  
FUJINO N, 1986, JPN J CLIN ONCOL, V16, P335
[9]  
GENDLER SJ, 1990, J BIOL CHEM, V265, P15286
[10]  
GION M, 1986, J NUCL MED ALLIED S, V30, P29